Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 11,831,461 | 10,597,181 | -1,234,280 | 196,402 | 272,348 | 45.97% | +75,945 |
| ASTRIA THERAPEUTICS INC | 0 | 2,872,537 | +2,872,537 | 0 | 25,680 | 4.34% | +25,680 |
| ENGENE HOLDINGS INC COM | 8,677,951 | 9,632,561 | +954,610 | 57,274 | 64,057 | 10.81% | +6,782 |
| ACHILLES THERAPEUTICS PLC | 2,390,050 | 2,390,050 | 0 | 2,438 | 2,749 | 0.46% | +311 |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | 6,044 | 2,427 | 0.41% | -3,617 |
| BICYCLE THERAPEUTICS PLC | 2,339,961 | 3,452,330 | +1,112,369 | 52,953 | 48,333 | 8.16% | -4,621 |
| REPLIMUNE GROUP INC(REPL) | 4,866,449 | 3,970,668 | -895,781 | 53,336 | 48,085 | 8.12% | -5,251 |
| DYNE THERAPEUTICS INC(DYN) | 5,954,069 | 5,462,846 | -491,223 | 213,870 | 128,705 | 21.73% | -85,166 |